Home > PE Ratio > VIMTA LABS

VIMTA LABS
PE (Price/Earnings) Ratio

The Current P/E Ratio of VIMTA LABS is 39.34.

Share Price ₹917.5Dec 11,2024
Market Cap ₹2,036.7 Cr
Earnings-TTM₹51.8 CrTTM-Consolidated Results
Price/Earnings39.34xCalculated as Market Cap/Earnings
Explore Stock Analytics
COMMUNITY POLL
for VIMTA LABS
Please provide your vote to see the results
VIMTA LABS is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks

Definition & Calculation of PE (Price/Earnings) ratio of VIMTA LABS

Price-to-Earnings ratio, P/E Multiple, or P/E Ratio is an important valuation multiple that is defined as:

P/E = Market Capitalization / Net Income

or, using per-share numbers:

P/E = Stock Price / Earnings Per Share (EPS)

Applying the above formula, P/E ratio of VIMTA LABS is calculated as :

Current Market Cap [ ₹2,036.7 Cr] as on Dec 11,2024

(/) Earnings [ ₹51.8 Cr] based on TTM-Consolidated Results

(=) P/E Ratio [ 39.34x ]

P/E Ratio indicates the multiple of earnings investors are willing to pay to own one share of the company.

Thus, for VIMTA LABS , the investors are currently willing to pay 39.34 times earnings to own 1 share of the company.

PE Multiples are the most widely used valuation multiple in practice.

Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.

In such cases, you may consider using Price to Book ratio or Price to Sales ratio of VIMTA LABS !

P/E ratios, also, would not adjust for differences in the capital structure between companies.

The chart below summarizes the trend in P/E Ratio of VIMTA LABS over the last five years.

Historical PE (Price/Earnings) ratio chart of VIMTA LABS


PE Ratio Performance Analysis for VIMTA LABS

- VIMTA LABS 's latest p/e ratio is 39.34x.

- VIMTA LABS 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 18.22x.

- VIMTA LABS 's operated at median p/e ratio of 16.86x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, VIMTA LABS 's p/e ratio peaked in Mar2024 at 24.04x.

- VIMTA LABS 's p/e ratio hit its five-year low in Mar2023 of 14.44x.


How does VIMTA LABS 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Earnings-TTM (Cr)PE RatioMarket Cap
VIMTA LABS 51.7839.342,036.7
SUN PHARMACEUTICAL INDUSTRIES LTD11,136.5039.10435,407.0
CIPLA LTD4,485.2226.18117,443.0
DR REDDYS LABORATORIES LTD5,406.8019.11103,338.0
ZYDUS LIFESCIENCES LTD4,298.9023.0999,244.9
DIVIS LABORATORIES LTD1,836.0085.78157,489.0
MANKIND PHARMA LTD2,124.8649.46105,098.0
TORRENT PHARMACEUTICALS LTD1,802.0063.38114,202.0
LUPIN LTD2,651.9436.9798,055.1
AUROBINDO PHARMA LTD3,598.8319.7871,188.9
ABBOTT INDIA LTD1,284.6647.7561,336.4

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs VIMTA LABS 's P/E Ratio

Top 10 Industry PeersPE Ratio
Min industry PE 19.11x
Max industry PE 85.78x
Median industry PE 39.10x
Average industry PE 40.90x



You may also like the below Video Courses